Intervention Protocol

Intravenous zoledronate for postmenopausal osteoporosis

  1. Ben-Hur Albergaria1,*,
  2. Brenda Nazaré Gomes Silva2,
  3. Álvaro N Atallah3,
  4. Virginia Fernandes Moça Trevisani4

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 20 JAN 2010

DOI: 10.1002/14651858.CD008332

How to Cite

Albergaria BH, Gomes Silva BN, Atallah ÁN, Fernandes Moça Trevisani V. Intravenous zoledronate for postmenopausal osteoporosis (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008332. DOI: 10.1002/14651858.CD008332.

Author Information

  1. 1

    Federal University of Espirito Santo, Osteoporosis Diagnosis and Research Center (CEDOES), Victoria, Espirito Santo, Brazil

  2. 2

    The Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  3. 3

    Universidade Federal de São Paulo / Escola Paulista de Medicina, Brazilian Cochrane Centre, São Paulo, SP, Brazil

  4. 4

    Universidade Federal de São Paulo, Rheumatology/Internal Medicine and Therapeutics, São Paulo, São Paulo, Brazil

*Ben-Hur Albergaria, Osteoporosis Diagnosis and Research Center (CEDOES), Federal University of Espirito Santo, Joao da Silva Abreu 78- Praia do Canto, Victoria, Espirito Santo, 29055 450, Brazil. benhur.gaz@terra.com.br.

Publication History

  1. Publication Status: New
  2. Published Online: 20 JAN 2010

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >